En valorisation
DAISY: The Impact and Safety of Dolutegravir-Based Antiretroviral Therapy in Young Children in West Africa
To describe the effects and tolerability of a regimen containing dolutegravir in children under 10 years of age living with HIV in West Africa.
Project Details
Principal Investigator
G B Hedible
Duration
39 months
Sponsor
NIH
Objectives
Main Objectives
To describe the effects and tolerability of a regimen containing dolutegravir in children under 10 years of age living with HIV in West Africa.
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Research Request
Estimated response time: 3-5 business days.
Keywords
OPERATIONS RESEARCH
OUR PROJECTS
COHORTE
